Mind Medicine To Conduct $25.0 Million Bought Deal Financing

Mind Medicine (CEO: MMED) announced that it will be conducting a bought deal financing this morning, to the tune of $25.0 million. The financing is being lead by Canaccord Genuity, with funds from the financing to be used for a number of clinical development initiatives that the company has planned for the near term.

$25.0 million in gross proceeds is expected to be raised via the sale of 23,810,000 units of the company at $1.05 per unit. Each unit is to consist of one subordinate voting share as well as one half warrant. Each warrant contains an exercise price of $1.40 per share, and is valid for three years from the date of issuance.

An over-allotment option also exists for the financing, which if fully exercised would result in additional gross proceeds of $3.75 million, bringing the total financing to $28.75 million. The over-allotment option is valid for a period of thirty days following the close of the transaction.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The proceeds from the financing are to be used for a number of clinical developments and initiatives, including:

  • Development of 18-MC
  • LSD microdosing
  • LSD experiential therapy for anxiety
  • MindMed Discover R&D
  • A training program at NYU Langone Health
  • A collaboration with University Hospital Basel Liechti Lab

Naturally, any remaining funds will be utilized for general working capital.

The financing is expected to close by October 30, 2020.

Mind Medicine last traded at $1.24 on the NEO.


Information for this briefing was found via Sedar and MindMed. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why I’m Still Bullish on Gold Below $3,900 | Wes Hanson – Thunder Gold

Is Agnico Eagle Seabridge Gold’s Mystery Lender?

This Gold Giant Is Building 1.5 Million More Ounces a Year | Agnico Eagle Q3 Earnings

Recommended

Epic Gold Delivers Maiden 279,000 Ounce Inferred Resource at Wilson Project

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Related News

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are...

Monday, June 14, 2021, 03:38:00 PM

Mind Medicine Returns To Trough For Further $25.0 Million

Mind Medicine (NEO: MMED) continues to take investor dollars, this morning announcing a bought deal...

Wednesday, November 25, 2020, 09:25:41 AM

Mind Medicine Raises $92.1 Million Via Bought Deal Financing

Mind Medicine (NEO: MMED) has closed its previously announced bought deal financing, raising nearly double...

Thursday, January 7, 2021, 09:31:54 AM

Proxy Fight Looms For MindMed Vs. Co-Founder

Mind Medicine’s (NASDAQ: MNMD) filed its preliminary proxy materials on Tuesday with the U.S. Securities and...

Wednesday, April 19, 2023, 09:43:00 AM

MindMed Adds MDMA To R&D Pipeline

Mind Medicine, also known as MindMed (NEO: MMED) this morning announced that it is branching...

Wednesday, May 27, 2020, 09:00:04 AM